Pilot Study to Examine the Use of Rivaroxaban After Angioplasty for Critical Limb Ischemia

NCT02260622 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Critical Limb Ischemia

Interventions

DRUG: rivaroxaban plus aspirin
DRUG: clopidogrel plus aspirin

Sponsor

Ottawa Hospital Research Institute

Collaborators

[object Object]